Cuban Policosanol
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
Cuban Policosanol. Sugar-cane–derived lipid-lowering long-chain alcohols.
How it works. Inhibits HMG-CoA reductase activation and modulates platelet aggregation.
What the research supports. 1 graded claims. Strongest: Lowers LDL in Cuban trials (not replicated by non-Cuban researchers) (limited).
How much to take. Typical dose: 10–20 mg.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Omega-3, CoQ10.
Common forms. Available as Capsule or softgel, Powder, Sublingual or buccal, Liposomal liquid.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried Cuban Policosanol. Anecdotes are not medical advice.
Cuban Policosanol. Sugar-cane–derived lipid-lowering long-chain alcohols.
What it is
Sugar-cane–derived lipid-lowering long-chain alcohols.
Food sources
Goals
How it works
Inhibits HMG-CoA reductase activation and modulates platelet aggregation.
Pathways
- Inhibits HMG-CoA reductase activation
- modulates platelet aggregation
Effects
- ↓LDL in Cuban trials (not replicated by non-Cuban researchers) decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- Headache
Medication interactions
Additive bleeding risk.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Omega-3Anti-inflammatory cardiovascular synergy.
- CoQ10Supports mitochondrial energetics in cardiac tissue.
Common forms
- Capsule or softgel
- Powder
- Sublingual or buccal
- Liposomal liquid
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching Cuban Policosanol and "Lowers LDL in Cuban trials". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Cuban Policosanol and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Cuban Policosanol and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…